CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 137 filers reported holding CYTOKINETICS INC in Q1 2019. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $829,564 | +81.9% | 28,159 | +101.4% | 0.10% | +22.2% |
| Q2 2023 | $455,995 | -42.9% | 13,979 | -31.2% | 0.08% | -62.3% |
| Q2 2022 | $799,000 | +125.1% | 20,328 | -53.6% | 0.22% | +22.9% |
| Q1 2019 | $355,000 | +177.3% | 43,844 | +317.6% | 0.18% | -55.7% |
| Q4 2016 | $128,000 | – | 10,500 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |